Optimal duration of anticoagulant therapy in patients with venous thromboembolism
Venous thromboembolism (VTE), a frequent and severe disease, has clinically important early and late complications and a strong tendency to recur. Anticoagulant therapy is the mainstay of treatment, performed by immediate administration of: a) parenteral anticoagulants followed by vitamin K antagon...
Main Author: | Gualtiero Palareti |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2018-09-01
|
Series: | Italian Journal of Medicine |
Subjects: | |
Online Access: | https://www.italjmed.org/index.php/ijm/article/view/1077 |
Similar Items
-
Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism
by: A. V. Rudakova
Published: (2015-01-01) -
Efficacy and safety of novel oral anticoagulants versus vitamin K antagonists in the treatment of venous thromboembolism
by: Maodi Xu, et al.
Published: (2018-09-01) -
Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events
by: O. V. Shatalova
Published: (2015-01-01) -
Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis
by: V. I. Petrov, et al.
Published: (2016-01-01) -
Implementation of international good clinical practice guidelines to improve care of patients with cancer-related venous thromboembolism
by: Rahaf Qari, et al.
Published: (2017-01-01)